xanthinol niacinate has been researched along with vinpocetine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Bandych-Biniszkiewiczowa, D; Pojda, SM | 1 |
Sanik, AV; Vesel'skiÄ, ISh | 1 |
BerdichevskiÄ, MIa; Dronnikova, IS; Onopchenko, NV | 1 |
4 other study(ies) available for xanthinol niacinate and vinpocetine
Article | Year |
---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[Personal experiences with conservative treatment of central retinal degeneration].
Topics: Administration, Oral; Adult; Aged; Cinnarizine; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Macular Degeneration; Male; Middle Aged; Procaine; Vinca Alkaloids; Visual Acuity; Vitamins; Xanthinol Niacinate | 1992 |
[The correction of microcirculatory disorders in patients with circulatory encephalopathy].
Topics: Adult; Conjunctiva; Female; Humans; Intracranial Arteriosclerosis; Male; Microcirculation; Middle Aged; Nicergoline; Vasodilator Agents; Vinca Alkaloids; Xanthinol Niacinate | 1991 |
[Effect of a series of vasoactive drugs on the compensatory adaptive processes of the brain during acute experimental cerebral venous stasis].
Topics: Adaptation, Physiological; Aminophylline; Animals; Brain; Cerebrovascular Disorders; Hydroxyethylrutoside; Pentoxifylline; Rats; Vasodilator Agents; Vinca Alkaloids; Xanthinol Niacinate | 1987 |